Difference between revisions of "Pharm Plan Minutes 2020.10.22"

From IHE Wiki
Jump to navigation Jump to search
Line 91: Line 91:
 
** Why not start with the requirements and compare the various FHIR resources  
 
** Why not start with the requirements and compare the various FHIR resources  
 
** We cannot wait until the JIC come with a decision. Should continue with use cases you have in supply and look for the best fit of which FHIR resource can be used as product.
 
** We cannot wait until the JIC come with a decision. Should continue with use cases you have in supply and look for the best fit of which FHIR resource can be used as product.
 +
 +
 +
** A suggestion to set up a new FHIR resource for Inventory report.
  
  

Revision as of 09:41, 22 October 2020

Meeting details =


Location

Morning login for Teams
Afternoon login for Teams


Minutes

Attendees:

  • Leonidas
  • Stephane
  • Esther
  • Michael
  • Marc
  • Jose


10:00-11:00 Opening and Committee work

  • Review Agenda
    • Agenda not changed
  • Review previous meeting notes
    • Corrected ( Oliver).
  • Schedule
  • Review and update Wiki
  • General
  • Roadmap
  • Strategic goals
  • Profile status discussion (public comment, final text, deprecated)
  • Which profiles profiles could be set to "Final text"? Candidates? Criteria?
  • Candidates for Final Text are:
    • PRE, DIS, PADV PML
    • But here has not enough testing. The results in 2019 with the new profiles are only from North America 2019 connectathon.
    • We decide to postpone to give the status of final text until we have more results from Connectathon. Probably until 2022
    • What is the status of the ELGA users? Is that only trial implementation?

11:00- 11:15 Break

11:15 - 12:00 Marcom & Promotion

  • Feedback from IHE Board meeting
    • Board report has been reported.
    • Comment:
      • Overview of countries and relation to which IHE profiles each country uses
      • The reported was appreciated.
      • Discussion about the HL7 about the product identification.
      • Topic will be further discussed during the supply topic

How to attract more people to IHE Pharmacy

  • Possible leads are the popular tracks:
    • supply
      • people are hesitating to join, because FHIR tools and methods are not clear for IHE profiles.
      • Also looking for backing at the IHE Europe sessions.
      • Looking for topics for November and December sessions.
      • One example are National incentives in Austria, Switzerland, Netherlands.
      • PATH has joined IHE, because HL7 is not really interested in supply. IHE Pharmacy does want to pick this up.
      • IHE will add workflows, which HL7 does not describe.
      • Hospitals are still pondering how to use FHIR. We could advise hospitals with this topic.


    • roll out in Switzerland. FHIR topics.
      • Stephane will promote our team during projectathon and call for volunteers.
      • Companies like HCI, they are reponsible for the pharmacy environment.
      • What about Oliver Egger? Or HL7 Switzerland. If Switzerland is moving from CDA to FHIR then it is important to give feedback about their experience back to IHE Pharmacy.
      • The projectathon organized a projectathon cafe, where Pharmacy was promoted.
    • Finding new topics with broad interest such as Vaccination?


  • Broadcast our message from IHE Pharmacy
  • Webinar series short topics.

12:00 - 16:00 Break

16:00 - 18:00 Supply topics

  • From the Whitepaper the group has set up the logical models.
  • This artificats need a product resource:
    • this could be a device, medication.
    • in the current situation the physical product is the lowest level
    • Common product pattern.
    • Why not start with the requirements and compare the various FHIR resources
    • We cannot wait until the JIC come with a decision. Should continue with use cases you have in supply and look for the best fit of which FHIR resource can be used as product.


    • A suggestion to set up a new FHIR resource for Inventory report.


Pharmacy Planning Committee